TPIV Stock News 3.2300 05/06/2014 04:10:10 Tapimmune Inc (TP

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tapimmune Inc (TPIV) 3.2300 $TPIV

TapImmune Inc. to Present at Invitation Only Corporate Roadshow in Boca Raton Florida
ACCESSWIRE - Thu Apr 24, 8:11AM CDT
Seattle WA / ACCESSWIRE / April 24, 2014 / TapImmune Inc. (OTCQB: TPIV), A clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease is pleased to announce that the company will be presenting at Corporate Road Show.com, in conjunction with, Undiscovered Equities.

TapImmune Inc. is Pleased to Provide an Update on Corporate Events and Milestones for 2014
Business Wire - Thu Apr 03, 10:03AM CDT
TapImmune Inc. (OTCQB:TPIV), A clinical stage immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease is pleased to update shareholders and investors on the most recent corporate events and milestones for the year ahead. Glynn Wilson TapImmune's CEO provided insights in an interview on the floor of the NASDAQ recently which can be seen by navigating to the following link:

TapImmune Chairman and CEO, Glynn Wilson, Ph.D. Provides Corporate Update on Company Progress
ACCESSWIRE - Tue Feb 25, 8:42AM CST
SEATTLE, WA / Feb 25, 2014 / ACCESSWIRE / TapImmune Inc. (OTCQB:TPIVD) Chairman and CEO, Glynn Wilson, Ph.D., has issued the following letter to the shareholders.

Janssen Announces New Group Targeting Unmet Global Health Needs
PR Newswire - Wed Jan 22, 7:15AM CST
Janssen, the pharmaceutical companies of Johnson & Johnson, today announced the formation of Janssen Global Public Health (Janssen GPH), an important new group unifying Janssen's commitment to research, develop, and deliver transformational medicines to address the world's greatest unmet public health needs. Janssen GPH will align the company's groundbreaking science and innovative access models under a single entity to drive better health outcomes, improve quality of life for patients, and sustainably advance health for people all over the world.

TapImmune Chairman Provides Corporate Update on Development Programs & Collaborations
ACCESSWIRE - Wed Jun 26, 10:31AM CDT
Seattle, WA, June 26, 2013 (eTeligis via ACCESSWIRE) -- TapImmune (OTCQB: TPIV)

TapImmune Inc names Sherry Grisewood to board
M2 - Thu Mar 21, 9:37AM CDT
Vaccine company TapImmune Inc (OTC BB:TPIV) revealed on Wednesday the appointment of Sherry Grisewood, CFA to the board of directors.

TapImmune Announces the Appointment of Sherry Grisewood to the Board of Directors
PR Newswire - Wed Mar 20, 8:00AM CDT
TapImmune Inc. (OTCQB: TPIV) has pleasure in announcing the appointment of Sherry Grisewood, CFA to the Board of Directors. She has over 25 years securities industry experience in a range of investment banking, advisory and research-related activities. She currently has a senior banking and banking analytical role at Dawson James Securities. Prior to joining Dawson James, she was Managing Director, Lifesciences and Technology Banking for Tripoint Global Equities. Sherry served as Senior Life Sciences Banker at Jesup & Lamont Securities Corp. and as an independent strategic advisor and consultant for several investment banks over the prior 12 year period. She has participated in over 50 transaction-related projects worldwide involving initial public offerings, secondary offerings, PIPE's, private equity, M&A and licensing transactions in the life sciences sector. Prior to consulting for investment banks, Sherry served as Director of Research for several mid-tier brokerage companies and a leading independent

TapImmune Inc. to Present at the Florida Road Show Conference on March 14, 2013
PR Newswire - Wed Mar 13, 8:00AM CDT
TapImmune Inc. ("TapImmune" or the "Company" (OTCQB: TPIV), an immunotherapy company focused on the development of novel peptide and gene-based vaccine technologies, announced today that the Company will present at the Florida Road Show Conference in Boca Raton, Florida on Thursday, March 14, 2013. This conference, hosted by Corporate Roadshow and Undiscovered Equities, will feature presentations by CEOs and CFOs of promising emerging growth companies to an invited audience of investment bankers, analysts, hedge-fund managers, top brokers and accredited investors.

OTC Signal Daily Stock Watch
WorldStockWire - Tue Jan 22, 11:28PM CST
OTC Signal tracks stocks daily and is pleased to offer its stock alerts. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Signal at the following: http://www.otcsignal.com

Positive Interim Safety Analysis Achieved in Breast Cancer Patients Treated with HER2/neu Antigens
PR Newswire - Wed Jan 09, 8:00AM CST
TapImmune Inc. (OTCBB: TPIV) has announced that an interim safety analysis on the first five breast cancer patients treated with HER2/neu Class II antigens at Mayo Clinic, Rochester, MN., did not show any serious adverse events. As a result treatment of the remaining 17 patients in the Phase I study, being conducted at Mayo Clinic, Rochester, MN will progress. The proprietary HER2/neu Class II antigens, discovered by Keith Knutson Ph.D. and colleagues at Mayo Clinic, show high affinity binding to human MHC proteins for ~84% of the population making it potentially applicable to a broad spectrum of HER2/neu patients compared to other approaches. The Phase I trial is being carried out in breast cancer patients who finished standard Herceptin®-based therapy and are at risk of disease recurrence. The primary endpoints of the study are safety and immunogenicity. Details of the Phase I trial can be found at http://clinicaltrials.gov. TapImmune is sponsoring the Phase I study and has an Exclusive Option to Li
Scroll down for more posts ▼

Top 10 Most Recent News Articles

HSBC Unveils $1B Tender Offer to Manage Capital Base

Updated Category News Views 102

HSBC's Strategic Capital Maneuver Alright, let's chew on this one: HSBC's out to repurchase up to a cool billion bucks worth of its own security paper. We're talking about the $3 billion, 6% Perpetual Subordinated Contingent Convertible Securities, which can be called up as soon as May 2027. Now, they're not going all-in—the offer is capped at $1 billion, though the...

Continue Reading
NACCO Navigates Strong 2026 Q3, Faces Solar Cost Hurdles

Updated Category News Views 44

Rolling With NACCO's Financial Punches Well, folks, when it rains, it pours—numbers that is. NACCO Industries just laid out their Q3 results for all to gawk at, and it's a mixed bag of triumphs and tussles. You got a gross profit of $11.8 million, a sweet 18% jump on the same quarter last year. Now, you're talking about revenue muscle, and there it is. Income before...

Continue Reading
Construction Partners' Georgia Move Bolsters Growth

Updated Category News Views 157

CPI's Strategic Expansion into Georgia Here's an acquisition to keep your eye on: Construction Partners, Inc. (NASDAQ: ROAD), also known in the corridors of trading as CPI, is making a move that many of us in the business have been anticipating for some time. They’ve wrapped up the acquisition of Piedmont Paving, Inc., a Newnan, Georgia-based company. Now, for most...

Continue Reading
International Book Launch Celebrates Chinese Garden Art

Updated Category News Views 103

Book Celebrates the Harmony of Nature and Culture The dusty pages of history crack open yet again, but this time with an aromatic whiff of oriental garden artistry. Some might say books and gardens don't share much beyond paper, mulch, and soil. But hold tight. This isn't just any old launch—it's the Harmony Between the Universe: International Perspectives on the Lion...

Continue Reading
LIME Faces Investigation Amid Earnings Shortfall

Updated Category News Views 73

Financial Miss Spurs Investigation When you've been in this racket as long as I have, you learn that missing consensus earnings even by a few cents can stir up a financial hornet's nest. That's precisely where Neutron Holdings Inc., better known as Lime, finds itself. With their third-quarter earnings slipping two cents below expectation, at $0.63 against a $0.66 to $0.68...

Continue Reading
Atlas Ocean Expands with New Epic Journeys for 2027-28

Updated Category News Views 67

Atlas Ocean Voyages' Grand Plans Anyone who's been sailing this rocky market sea long enough knows there’s no better place to gauge the winds than from a cozy captain's chair—so picture this: Atlas Ocean Voyages just dropped a 2027-28 roadmap that’s more of an atlas in its own right. We’re talking epic voyages spanning Europe, the Med, and Arctic realms, all while...

Continue Reading
Utility Returns: Short-Term Savings, Long-Term Costs

Updated Category News Views 41

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Continue Reading
Vermiculus Taps New CISO Amid Index Engine Launch

Updated Category News Views 38

Vermiculus Ups Its Security Game You ever wonder why a company decides to beef up security? Well, Vermiculus ain't leaving anything to chance as they roll out new tech. They've named Alexander Kilian the Chief Information Security Officer. Yep, Kilian's stepping into the ring, and no one’s treating this like a sidebar gig. This market tech outfit isn't just polishing...

Continue Reading
Cardinal Health Surges with Increased EPS Outlook

Updated Category News Views 99

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Continue Reading
Admetec Shines Bright with New High-Magnification Headlights

Updated Category News Views 80

Admetec's Leap into Advanced Optical Solutions In the world of optical magnification, getting the right balance of visibility and comfort hasn't always been a straightforward journey. Now, Admetec, coming out of Haifa, Israel, is throwing a game-changer into the mix with their announcement of the Butterfly EVO+ and Orchid+ series. These ain't just any old headlights;...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Market Sentiment for SBA Communications Corp

Updated Category News Views 212

Exploring the Market Sentiment for SBA Communications Corp SBA Communications Corp (NYSE: SBAC) has recently shown a notable shift in its short interest. The percentage of shares sold short as a part of the float has decreased by 15.04% since the last report. Recent data reveals that there are currently 2.02 million shares sold short, representing 2.26% of all regular...

Continue Reading
VAST Data and Equinix Unite to Advance AI Infrastructure Solutions

Updated Category News Views 166

VAST Data and Equinix teamed up back in 2024, shaking things up in the tech landscape with their ambitious push into AI solutions. Traders watched closely as these two heavyweights aimed to create a next-gen infrastructure for AI applications that leveraged VAST’s innovative data platform alongside NVIDIA's high-octane DGX systems. The scene was electric, but let’s...

Continue Reading
BingX Launches Perpetual Trading on TradingView for Users

Updated Category News Views 245

BingX Unveils Perpetual Trading on TradingView BingX, a leading global cryptocurrency exchange, is thrilled to announce the introduction of perpetual trading on TradingView, a renowned platform recognized for its advanced charting and analytical capabilities. This innovative feature seamlessly combines BingX's robust trading infrastructure with TradingView's exceptional...

Continue Reading
Predictions for DocuSign's Earnings Growth and Analyst Insights

Updated Category News Views 61

DocuSign’s Upcoming Earnings Report: What to Expect DocuSign, Inc. (NASDAQ: DOCU) is preparing to release its earnings report for the second quarter shortly. Analysts anticipate that the company will report earnings of 80 cents per share, which is an increase from last year's earnings of 72 cents per share. Additionally, revenue is expected to be around $727.36 million....

Continue Reading
Frontline Education and Vanco Enhance Partnership with RevTrak

Updated Category News Views 155

Frontline Education and Vanco Strengthen Partnership with RevTrak Frontline Education, a leading provider of administrative software for K-12 schools, and Vanco, a top fintech company known for its integrated software and payment technology, have announced an exciting expansion of their partnership. This enhancement builds on their successful collaboration and now...

Continue Reading